The largest database of trusted experimental protocols

13 protocols using 462 tec

1

Osteoclast Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After seeding for 24 h, cells were plated in triplicate and pre-treated for 30 min with four different conditions as mentioned earlier, followed by a 5-day incubation with 50 ng/mL soluble RANKL (462-TEC, R&D systems, Minneapolis, MN, USA) to induce osteoclastogenesis. Subsequently, cells were fixed in 4% paraformaldehyde for 10 min, and then stained for determination of TRAP activity. A commercial TRAP staining kit (Cosmo Bio, Tokyo, Japan) was used at 37 °C for 60 min to determine osteoclast formation. TRAP-positive multinucleated cells, which had more than 3 nuclei, were considered to denote achievement of osteoclast differentiation. The osteoclast number was finally determined using ImageJ software (NIH, MA, USA).
+ Open protocol
+ Expand
2

Osteoclast Differentiation from Murine Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells from 8- to 12-wk-old Notumflox/flox and Runx2-creNotumflox/flox mice were cultured in suspension culture discs (Corning) in complete α-MEM with 30 ng/ml macrophage colony-stimulating factor (M-CSF) (416-ML-050; R&D Systems, Minneapolis, MN, USA) for 2 d, and the adherent bone marrow–derived macrophages (BMMs) were used as osteoclast progenitors (28 (link), 29 (link)). BMMs were detached and spot seeded in 24-well plates (40,000 cells/well) and cultured in complete α-MEM with 30 ng/ml M-CSF with or without the addition of 4 ng/ml receptor activator of nuclear factor κ-B ligand (RANKL) (462-TEC; R&D Systems) to induce osteoclast differentiation. The medium was changed after 3 d and cells harvested for RNA isolation by lysis in RLT buffer (Qiagen, Germantown, MD, USA) 4 d after seeding.
+ Open protocol
+ Expand
3

Osteoclast Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the osteoclast differentiation assay, mouse bone marrow macrophages (BMMs) were harvested from bone marrow cells in the long bones of 8-week-old wild-type mice (C57BL/6J, The Jackson Laboratory, Sacramento, CA, USA). In brief, bone marrow cells were flushed out from the femurs and tibias, treated with red blood cell lysis buffer, and suspended in 10% fetal calf serum (FCS) and 1% penicillin/streptomycin (Corning, New York, NY, USA). Cells were cultured in the presence of M-CSF (10 ng/mL, R&D Systems, Minneapolis, MN, USA, 416-ML), and 1 day later, non-adherent cells were plated at a density of 0.5 × 106 cells/well in 24-well plates. BMMs were differentiated into osteoclasts by treating them with M-CSF (10 ng/mL) and RANKL (20 ng/mL, R&D Systems, 462-TEC), and two days later, liquid chlorobenzene was added daily at four concentrations (0 (control), 1, 10, and 100 µg/mL) for 14 days. To assess osteoclast differentiation, TRAP staining was performed using a leukocyte acid phosphatase staining kit (Sigma, 387A) according to the manufacturer’s protocol. The TRAP-stained osteoclasts were detected using an Evos microscope (Applied Biosystems, Waltham, MA, USA).
+ Open protocol
+ Expand
4

Osteoclast Differentiation in Bone Marrow Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We cultured 1 x 105 bone marrow cells, isolated from 7–8-week-old WT, Dcstamp-/-, Tg(hTNF) and Dcstamp-/-;Tg(hTNF) mice, in a 96-well plates in alpha - DMEM media supplemented with 10 μg/mL of M-CSF (415-ML, R&D system, Minneapolis., MN) 2 mM L-glutamine, 100 μg/mL streptomycin, 1 mM of non-essential amino acids, 1 mM sodium pyruvate, and 0.5 μM of amphotericin B. On day three, fresh media containing 10 μg/mL of M-CSF and 10 μg/mL of RANKL was added (462- TEC, R&D system, Minneapolis., MN) and cell cultures were maintained for additional four days. Cells were then fixed with citrate/37% of formaldehyde solution. Osteoclast differentiation was evaluated with a TRAP activity kit according to the manufacturer’s instructions (387A, Sigma-Aldrich Co LLC. St Louis., MO).
+ Open protocol
+ Expand
5

Isolation and Culture of Murine Bone Marrow Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were flushed from femurs and tibias from 8 to 12 week-old C57BL/6N mice, washed and cultured in complete α-MEM with 30 ng·mL−1 M-CSF (R&D, 416-ML-050) in a suspension culture dish (Corning Costar Ins., NY), to which stromal cells and lymphoid cells cannot adhere, at 37 °C for 2–3 days. Cells were washed vigorously with PBS to remove any non-adherent cells and then washed with cold (4 °C) 0.02% EDTA in PBS to release the attached bone marrow macrophages (BMM). BMM purity was demonstrated by expression of the monocyte marker CD11b/Mac-1 in all cells, whereas no cells expressed the T- and B-cells markers CD45R and CD3. Cells were spot seeded in 24-well plates (40 000 cells in 40 μL complete α-MEM). For osteoclast generation, cells were cultured in 30 ng·mL−1 M-CSF and 4 ng·mL−1 RANKL (R&D, 462-TEC) for 3–4 days.
+ Open protocol
+ Expand
6

Macrophage and Osteoclast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total bone marrow cells were harvested from femurs and tibias of 6-month-old Scarb1fl/fl and LysM-Cre;Scarb1fl/fl mice. After removing red blood cells with ACK buffer (0.1 mM EDTA, 10 mM KHCO3 and 150 mM NH4Cl, pH 7.2–7.3), bone marrow cells were plated in 10 cm tissue culture plates with 10 ml α-MEM complete media (10 % fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin) supplemented with macrophage colony-stimulating factor (M-CSF; 30 ng/ml; cat. 216-MC, R&D Systems Minneapolis, MN). After 24 h of incubation, non-adherent cells were plated in Petri dishes (10 cm) and cultured with 10 ml α-MEM complete media supplemented with M-CSF (30 ng/ml) for 4 days. Those cells were used to culture macrophages and osteoclasts for analysis of mRNA and gDNA.
To obtain mRNA and genomic DNA, cells were then plated in 6-well plates at a density of 0.3 × 106 cells/well with 1.5 ml of α-MEM complete media supplemented with 30 ng/ml M-CSF for 3 days to obtain macrophages and with 30 ng/ml M-CSF and 30 ng/ml RANKL (RANKL cat. 462-TEC, R&D Systems, Minneapolis, MN, USA) for 3 days to obtain osteoclasts.
+ Open protocol
+ Expand
7

Osteoclast Formation Assay with Exosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For studies on osteoclast formation and differentiation, cells from the monocytic cell line RAW264.7 were seeded in 24 well plates at a density of 1,5x104 cells per well. After an initial attachment period of 24 hours, the cells were cultured in the absence (control) or presence of recombinant mouse RANKL (RANKL; 462-TEC, R&D Systems) at a concentration of 2 ng/mL, alone or in combination with exosomes for 96 h. Exosomes from either TRAMP-C1 tumor cells or MLg fibroblastic cells were added at two different concentrations, a higher concentration of 50 ng/103 seeded cells, or the lower concentration of 10 ng/103 seeded cells. After 96 h of culture, the cells were washed twice with PBS, fixed with ice-cold methanol for 10 minutes and stained for tartrate-resistant acid phosphatase (TRAP) using the Leukocyte Acid Phosphatase kit (Sigma-Aldrich) according to the manufacturer’s recommendations. Cells positive for TRAP with ≥ 3 nuclei were considered osteoclasts and counted.
+ Open protocol
+ Expand
8

Polarization of Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were seeded in a six-well plate at an initial density of 5×105 cells per well and induced with 100 ng·mL−1 LPS (L3012, Sigma-Aldrich), 100 ng·mL−1 IFN-γ (285-IF, R&D System), LPS+IFN-γ, and RANKL (462-TEC, R&D Systems, Minneapolis, MN, USA) at different concentrations (1, 10, and 100 ng·mL−1) for 12 h. Polarized cells were harvested for mRNA analysis by reverse reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
+ Open protocol
+ Expand
9

Osteoclastogenesis Modulation by Curcuminoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cells were pre-treated with curcumin, DMC, or BDMC (all purchased from Chromadex) in media (DMEM + 10% FBS + 1% pen/strep) for 4 h at 37°C with 5% CO2 followed by stimulation with receptor activator of NF-κB ligand (RANKL, 50 ng/mL final concentration, R&D #462-TEC) and further incubation at 37°C for 72 h. Tartrate-resistant acid phosphatase (TRAP) positive, multi-nucleated (n≥3) osteoclasts were visually quantified by microscopy.
+ Open protocol
+ Expand
10

Macrophage and Osteoclast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total bone marrow cells were harvested from femurs and tibias of 6-month-old Scarb1fl/fl and LysM-Cre;Scarb1fl/fl mice. After removing red blood cells with ACK buffer (0.1 mM EDTA, 10 mM KHCO3 and 150 mM NH4Cl, pH 7.2–7.3), bone marrow cells were plated in 10 cm tissue culture plates with 10 ml α-MEM complete media (10 % fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin) supplemented with macrophage colony-stimulating factor (M-CSF; 30 ng/ml; cat. 216-MC, R&D Systems Minneapolis, MN). After 24 h of incubation, non-adherent cells were plated in Petri dishes (10 cm) and cultured with 10 ml α-MEM complete media supplemented with M-CSF (30 ng/ml) for 4 days. Those cells were used to culture macrophages and osteoclasts for analysis of mRNA and gDNA.
To obtain mRNA and genomic DNA, cells were then plated in 6-well plates at a density of 0.3 × 106 cells/well with 1.5 ml of α-MEM complete media supplemented with 30 ng/ml M-CSF for 3 days to obtain macrophages and with 30 ng/ml M-CSF and 30 ng/ml RANKL (RANKL cat. 462-TEC, R&D Systems, Minneapolis, MN, USA) for 3 days to obtain osteoclasts.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!